World PulseNow

Trending Stories

Loading trending stories...

Heatmap
About UsNews SourcesSubscribeMobileContact UsPrivacy Policy
© 2025 World Pulse Now
Language:
Search
Instantly search thousands of news articles from trusted sources.
HomeTrending StoriesWeight Loss
Show me
Eli Lilly's Experimental Weight-Loss Drug Shows Promise Despite Stock Drop
2articles
Weight LossHealth
Updated a few seconds ago

Eli Lilly's Experimental Weight-Loss Drug Shows Promise Despite Stock Drop

Eli Lilly's experimental oral weight-loss drug demonstrated potential in trials, helping participants lose up to 12% of their body weight. However, the results were less effective than anticipated, leading to a significant drop in the company's shares. Despite this, the drug could make obesity treatment more accessible, with expectations for market release next year.

Related Articles
Heard on the Street: An oral weight-loss drug could finally bring obesity treatment to the masses
Dow Jones - Health6 days ago
Heard on the Street: An oral weight-loss drug could finally bring obesity treatment to the masses
NeutralHealth
Eli Lilly's experimental oral weight-loss drug showed less effectiveness than expected in trials, causing its shares to drop. However, the drug still has significant potential to make obesity treatment more accessible to a wider population.
Editor’s Note: While the drug didn't meet high expectations, it could still be a game-changer by offering an easier, more scalable alternative to current obesity treatments like injections. This matters because obesity is a major global health issue, and a pill form could help more people get treatment.
Read full article
via Dow Jones - Health
An experimental weight-loss pill from Eli Lilly helped people lose up to about 12% of their body weight, a new study found, potentially clearing the way for the drug to be on the market next year
Dow Jones - Health7 days ago
An experimental weight-loss pill from Eli Lilly helped people lose up to about 12% of their body weight, a new study found, potentially clearing the way for the drug to be on the market next year
NeutralHealth
A new study shows that Eli Lilly's experimental weight-loss pill helped participants lose up to 12% of their body weight, potentially paving the way for its market release next year. This pill could offer an alternative to weight-loss injections, though the company's stock dropped by over 10% despite the promising results.
Editor’s Note: This story matters because it highlights a potential breakthrough in obesity treatment—a pill that could be more convenient than injections. However, the stock dip suggests investor uncertainty, so while the science looks promising, the market reaction adds a layer of complexity.
Read full article
via Dow Jones - Health

Why World Pulse Now?

Global Coverage

All major sources, one page

Emotional Lens

Feel the mood behind headlines

Trending Stories

Know what’s trending, globally

Read Less, Know More

Get summaries. Save time

Multi-Language

Switch languages to read your way

Save for Later

Your stories, stored for later

Stay informed, save time
Learn more

Live Stats

Articles Processed

5,477

Trending Stories

203

Sources Monitored

191

Last Updated

in 7 hours

Live data processing
How it works

Mobile App

Available on iOS & Android

The mobile app adds more ways to stay informed — including offline reading, voice-enabled summaries, and personalized trend alerts.

Get it on Google PlayDownload on the App Store
Available now on iOS and Android

1-Minute Daily Briefing

Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more

By subscribing, you agree to our Privacy Policy